FDA rejects J&J premature ejaculation drug
The FDA has rejected Johnson & Johnson’s application for its experimental drug to treat premature ejaculation, the company said yesterday.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.